This article provides a comprehensive analysis of Endocrine-Disrupting Chemical (EDC) exposure routes—food, air, and skin absorption—and their implications for human health and drug development.
This article provides a comprehensive analysis of the comparative effectiveness of available osteoporosis medications in reducing fracture risk, tailored for researchers, scientists, and drug development professionals.
This article synthesizes current evidence on the long-term cognitive effects of menopausal hormone therapy (MHT), addressing a critical area of concern and opportunity in women's brain health.
This article addresses the critical global challenge of undertreatment in post-fracture osteoporosis, a condition affecting over 500 million people worldwide.
This article synthesizes current evidence on the age-dependent outcomes of vitamin D supplementation, a critical area for research and drug development.
This article provides a critical comparison for researchers and drug developers between Growth Hormone Secretagogues (GHSs) and recombinant human Growth Hormone (rhGH).
This article provides a scientific review of Human Growth Hormone (HGH) and Testosterone therapy for modifying body composition, tailored for researchers and drug development professionals.
This article systematically reviews the differential impact of oral and transdermal estrogen administration on the Growth Hormone (GH)/Insulin-like Growth Factor-1 (IGF-1) axis, a critical pathway with broad implications for metabolism,...
This article provides a comprehensive analysis of vitamin D deficiency management for the aging population, tailored for researchers and drug development professionals.
This article provides a critical analysis of growth hormone (GH) therapy for age-related decline, synthesizing foundational science, clinical application methodologies, and risk mitigation strategies.